• 1. Emulsion soft templating of carbide-derived carbon nanospheres with controllable porosity for capacitive electrochemical energy storage?
  M. Zeiger,N. J?ckel,P. Strubel,L. Borchardt,R. Reinhold,W. Nickel,J. Eckert,V. Presser,S. Kaskel J. Mater. Chem. A, 2015,3, 17983-17990
• 2. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita
• 3. Distinct correlation between (CN2)x units and pores: a low-cost method for predesigned wide range control of micropore size of porous carbon?
  Xiaotong Feng,Lei Bian,Jie Ma,Lei Zhou,Xiayan Wang,Guangsheng Guo,Qiaosheng Pu Chem. Commun., 2019,55, 3963-3966
• 4. Emerging enantiomeric resolution materials with homochiral nano-fabrications
  Ji-Ping Wei Nanoscale, 2015,7, 11815-11832
• 5. Evolution of hierarchical porous structures in supramolecular guest–host hydrogels?
  Christopher B. Rodell,Christopher B. Highley,Minna H. Chen,Neville N. Dusaj,Chao Wang,Lin Han,Jason A. Burdick Soft Matter, 2016,12, 7839-7847

Introduction to Methyl 7-aminobenzothiophene-2-carboxylate (CAS No: 616238-78-9)

Methyl 7-aminobenzothiophene-2-carboxylate (CAS No: 616238-78-9) is a specialized organic compound that has garnered significant attention in the field of pharmaceutical research and chemical synthesis. This compound, characterized by its benzothiophene core structure, serves as a crucial intermediate in the development of various bioactive molecules. The benzothiophene scaffold is particularly notable for its presence in numerous pharmacologically relevant compounds, making it a subject of extensive study and application.

The molecular structure of methyl 7-aminobenzothiophene-2-carboxylate consists of a benzene ring fused with a thiophene ring, with an amino group (-NH?) at the 7-position and a carboxylate ester (-COOCH?) at the 2-position. This unique arrangement imparts distinct chemical properties that make it valuable for synthetic chemistry. The presence of both the amino and carboxylate functional groups provides multiple sites for further chemical modification, enabling the synthesis of more complex derivatives.

In recent years, significant advancements have been made in understanding the pharmacological potential of benzothiophene derivatives. Research has highlighted their role in various therapeutic applications, including antimicrobial, anti-inflammatory, and anticancer agents. The compound methyl 7-aminobenzothiophene-2-carboxylate, due to its structural features, has been explored as a precursor in the synthesis of novel drugs targeting these conditions.

One of the most compelling aspects of methyl 7-aminobenzothiophene-2-carboxylate is its utility in medicinal chemistry. The benzothiophene moiety is known to exhibit strong binding affinity to biological targets, making it an ideal candidate for drug design. For instance, studies have demonstrated its effectiveness in modulating enzyme activity and receptor interactions, which are critical for therapeutic intervention. The amino group at the 7-position can be further functionalized to enhance binding specificity, while the carboxylate ester group offers a versatile handle for conjugation reactions.

The synthesis of methyl 7-aminobenzothiophene-2-carboxylate involves multi-step organic reactions that require precise control over reaction conditions. Typically, the process begins with the formation of the benzothiophene core through cyclization reactions involving appropriate precursors. Subsequent functionalization steps introduce the amino and carboxylate ester groups at specific positions on the ring system. Advanced synthetic methodologies, such as palladium-catalyzed cross-coupling reactions, have been employed to achieve high yields and purity levels.

Recent research has also explored the role of methyl 7-aminobenzothiophene-2-carboxylate in developing targeted therapies for cancer. Studies have shown that benzothiophene derivatives can inhibit key enzymes involved in tumor growth and metastasis. The compound’s ability to selectively interact with cancer cell targets makes it a promising candidate for further investigation. Additionally, its structural flexibility allows for the design of analogs with enhanced pharmacokinetic properties, such as improved solubility and bioavailability.

In conclusion, methyl 7-aminobenzothiophene-2-carboxylate (CAS No: 616238-78-9) is a versatile intermediate with significant potential in pharmaceutical applications. Its unique structural features and functional groups make it valuable for synthesizing bioactive molecules targeting various diseases. Ongoing research continues to uncover new ways to leverage this compound’s properties for therapeutic benefit, underscoring its importance in modern drug discovery and development.

• 83716-04-5(Methyl 3-(methylamino)benzo[b]thiophene-2-carboxylate)
• 181282-81-5(Dimethyl 3-aminobenzo[b]thiophene-2,5-dicarboxylate)
• 383675-06-7(Ethyl 5-Amino-1-benzothiophene-2-carboxylate Hydrochloride)
• 34761-09-6(ethyl 3-amino-1-benzothiophene-2-carboxylate)
• 25785-10-8(ethyl 5-amino-1-benzothiophene-2-carboxylate)
• 35212-85-2(methyl 3-amino-1-benzothiophene-2-carboxylate)
• 181284-94-6(3-Amino-4-methyl-benzobthiophene-2-carboxylic Acid Ethyl Ester)
• 1036380-75-2(Methyl 3-Amino-5-bromobenzobthiophene-2-carboxylate)
• 330801-72-4(Benzo[b]thiophene-2-carboxylicacid, 4-amino-, methyl ester)
• 20699-85-8(Methyl 5-Aminobenzobthiophene-2-carboxylate)